Los costos de envío se calcularán en base a esta dirección en todo el sitio.
Selecciona tu país
América
Argentina
Brasil
Canadá
Chile
Colombia
Costa Rica
Ecuador
El Salvador
Estados Unidos
México
Perú
República Dominicana
Uruguay
Europa
Alemania
Austria
Bélgica
Croacia
Dinamarca
Eslovaquia
Eslovenia
España
Finlandia
Francia
Grecia
Hungría
Irlanda
Italia
Letonia
Malta
Noruega
Países Bajos
Polonia
Portugal
Reino Unido
República Checa
Serbia
Suecia
Suiza
Resto del mundo


Immunotherapy (en Inglés)
Aung Naing;Joud Hajjar (Autor) · Springer Nature B.V. · Tapa Blanda
Quedan 50 unidades
$ 48.58The field of immuno-oncology continues to rapidly evolve as new insights to fight and treat cancer emerge. The fourth edition of Immunotherapy provides the most current overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. While immunotherapy has revolutionized the treatment landscape of several solid malignancies, several challenges still exist.
Only a subset of patients derive clinical benefits; some do not respond at all, and others respond initially, only for their disease to progress later. Because these drugs can activate a broad range of immune cells, patients suffer from a unique set of side effects known as immune-related adverse events. As more immunotherapeutic agents are used in the clinic, it is important to provide updates about current and ongoing developments in the field to further research efforts and inform treatment decisions.The fourth edition will have a new focus on strategies to overcomethe challenges associated with immunotherapy. Chapters will discuss topics such as biomarkers of response, resistance mechanisms, role of imaging in predicting immune-related adverse events, and management of immune-related adverse events. Written by leading experts conducting cutting-edge research, readers will gain up-to-date knowledge on the current state and future of immunotherapy.¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

